Fleury S.A. (FLRY3.SA)
| Previous Close | 14.58 |
| Open | 14.59 |
| Bid | 14.64 x 0 |
| Ask | 14.64 x 0 |
| Day's Range | 14.32 - 14.79 |
| 52 Week Range | 13.53 - 27.88 |
| Volume | |
| Avg. Volume | 2,859,681 |
| Market Cap | 4.64B |
| Beta (5Y Monthly) | 1.05 |
| PE Ratio (TTM) | 11.18 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.96 (5.86%) |
| Ex-Dividend Date | Dec 22, 2021 |
| 1y Target Est | N/A |
- Yahoo Finance
Miami F1 race a big boon for the sport — and for big brands
While it was a win for Max Verstappen and Red Bull, the Miami GP was also a big win for Formula 1 and its various teams and sponsors, several of which are large, multinational publicly traded companies which are keen to be associated with the growing U.S. F1 audience.
- Simply Wall St.
Those who invested in Monster Beverage (NASDAQ:MNST) five years ago are up 82%
Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...
- Reuters
UPDATE 1-Brazil lab chain Fleury acquires Marcelo Magalhaes for $70 mln
Brazilian lab chain Fleury SA has reached a deal to acquire lab company Marcelo Magalhaes Diagnosticos for 384.5 million reais ($70.12 million), it said in a securities filing on Monday. The deal will increase Fleury's footprint in the Brazilian state of Pernambuco to 31 patient service centers, the company said, adding that Marcelo Magalhaes had a gross revenue of 114 million reais in the 12 months to July 2021. Fleury said the deal implies an EV/EBITDA multiple of 7.5x for 2024, "considering the synergies to be capture after the conclusion of the transaction", which still requires approval from Brazil's antitrust watchdog.
